01 1Piramal Pharma Solutions
01 1DEFERASIROX
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-11-05
Pay. Date : 2018-09-25
DMF Number : 31485
Submission : 2017-03-29
Status : Active
Type : II
20
Piramal Pharma Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Piramal's expertise across varied technologies makes them a partner of choice for innovators & generic companies worldwide.
One of their notable products is DEFERASIROX, with a corresponding US DMF Number 31485.
Remarkably, this DMF maintains an Active status since its submission on March 29, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 05, 2018, and payment made on September 25, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
